The APIs listed below are the main Anti-Emetic ingredients that are presently available from LGM Pharma:
We constantly aim to provide top technical support and full regulatory documentation (TDP / CTD / E-DMF / CEP / US-DMF etc…) even for the most recently approved APIs, originating from EU-GMP certified and US-FDA approved production facilities. Many of the above APIs are manufactured via non-infringing routes of synthesis and would be suitable for Paragraph IV challenges / early launch in regulated markets.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1).
Any patent infringement and resulting liability is solely at buyer risk.
Summary
Article Name
Anti-Emetics
Description
We continuously endeavor to provide our clients with the newest APIs for ongoing research and/or product development efforts.
Author
LGM Pharma
Publisher Name
LGM Pharma
Publisher Logo